Search results for “11 β hydroxysteroid dehydrogenase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 105 patents, we discovered top 26 key players by total patent application. Biovitrum AB, Boehringer Ingelheim International GmbH, Amgen, Inc. are dominant in this area. They take 47.62% of the total patent filing.
Biovitrum AB
Sweden
Patent: 21
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 16
Amgen, Inc.
California, United States
Patent: 13
Connexios Life Sciences Pvt Ltd.
Karnataka, India
Patent: 12
Shionogi & Co., Ltd.
Osaka-fu, Japan
Patent: 10
AbbVie, Inc.
Illinois, United States
Patent: 8
Eli Lilly & Co.
Indiana, United States
Patent: 5
Abbott Laboratories
Illinois, United States
Patent: 3
High Point Pharmaceuticals LLC
North Carolina, United States
Patent: 3
vTv Therapeutics LLC
North Carolina, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: